Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
In March, the Danish developer revealed Phase I data for the oral asset, highlighting a 13.1% weight loss at 12 weeks, versus 1.1% for placebo
Diabetes Care, 48(2), 292-300
Read More GLP1s for Obesity: What LongTerm Treatment Really Means for Diabetes Care Jan 9, 2026 Articles, Diabetes, Feature, Obesity, Therapies, Type 2 Diabetes, Type 2 Diabetes 1,742 views The rise of GLP-1 obesity treatment has transformed how clinicians approach patients with both obesity and diabetes
In stock Description Additional information COA (Certificates of Analysis) About Ipamorelin Ipamorelin Product Data About CJC-1295 DAC CJC-1295 Product Data References Why this stack Key highlights Two 5 mg lyophilized vials One vial each of CJC-1295 DAC and Ipamorelin, freeze-dried in sterile, UV-resistant glass vials
